Convelo Therapeutics

0 followers


Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sc... Read more

Industries

Employees

11-50

Links

Org chart

Derrick Rossi
President & CEO

Derrick Rossi

Collapse
Paul Tesar
Vice President Of Biology
Drew Adams
Convelo/genentech Project Team Co-lead
Brad Lang
VP of Research, Biology Team Lead
Dan Factor
Director Of Discovery
Edmond Mok
Vice President of Finance (Consultant)
Samantha Stubblefield
VP, Operations & Program Management